Literature DB >> 479376

Staphylococci-induced human platelet injury mediated by protein A and immunoglobulin G Fc fragment receptor.

J Hawiger, S Steckley, D Hammond, C Cheng, S Timmons, A D Glick, R M Des Prez.   

Abstract

Bloodstream infections with staphylococci are accompanied by thromboembolic complications. We have studied the mechanism of the interaction of staphylococci with human blood platelets. Staphylococci that possess protein A, a bacterial receptor for the Fc fragment of immunoglobulin G (IgG), caused aggregation of human platelets in whole plasma accompanied by release of [(3)H]serotonin. These reactions were time and concentration dependent, requiring two or more staphylococci per platelet to give maximal response within 5 min. The interaction between staphylococci and platelets required the presence of cell wall-bound protein A and of IgG with an intact Fc fragment. It did not require an intact complement system. Cell wall-bound protein A (solid phase) was capable of aggregating human platelets in whole plasma. In contrast, free, solubilized protein A (fluid phase) did not cause measurable aggregation, and release of [(3)H]serotonin was reduced. An excess of free, solubilized protein A blocked aggregation of human platelets induced by staphylococci in whole plasma. The role of the Fc fragment of IgG in the staphylococci-human platelet interaction was demonstrated by an experiment in which free, isolated Fc fragment blocked aggregation of platelets in whole plasma induced by staphylococci. Furthermore, binding of (125)I-protein A to human platelets was demonstrated in the presence of complete IgG with intact Fc fragment but not in the presence of the F(ab)(2) fragment. Binding of the protein A-IgG complex to the human platelet Fc receptor was paralleled by the release of [(3)H]serotonin. These results represent a novel example of the interaction of two phylogenetically different Fc receptors, one on prokaryotic staphylococci and the other on human platelets. Their common ligand, IgG, is amplified by one Fc receptor (protein A) to react with another Fc receptor present on human platelets, which results in membrane-mediated aggregation and release reaction occurring in whole plasma. This mechanism can be of significance in the pathomechanism of thromboembolic complications at the site(s) of intravascular staphylococcal infection.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 479376      PMCID: PMC372201          DOI: 10.1172/JCI109559

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

1.  THE COMMON PROTEIN AGGLUTINOGEN OF STAPHYLOCOCCUS AUREUS. II. PURIFICATION, CHEMICAL CHARACTERIZATION, AND SEROLOGIC COMPARISON WITH JENSEN'S ANTIGEN.

Authors:  A YOSHIDA; S MUDD; N A LENHART
Journal:  J Immunol       Date:  1963-12       Impact factor: 5.422

2.  Aggregation of blood platelets by adenosine diphosphate and its reversal.

Authors:  G V BORN
Journal:  Nature       Date:  1962-06-09       Impact factor: 49.962

3.  Structural units of human 7S gamma globulin.

Authors:  E C FRANKLIN
Journal:  J Clin Invest       Date:  1960-12       Impact factor: 14.808

4.  Non-suppurative lesions in staphylococcal septicaemia.

Authors:  D E POWELL
Journal:  J Pathol Bacteriol       Date:  1961-07

5.  Human gamma globulin fractionation on anion exchange cellulose columns.

Authors:  J L FAHEY; A P HORBETT
Journal:  J Biol Chem       Date:  1959-10       Impact factor: 5.157

6.  The hydrolysis of rabbit y-globulin and antibodies with crystalline papain.

Authors:  R R PORTER
Journal:  Biochem J       Date:  1959-09       Impact factor: 3.857

7.  Studies on the interaction between protein A and immunoglobulin G. I. Effect of protein A on the functional activity of IgG.

Authors:  J J Langone; M D Boyle; T Borsos
Journal:  J Immunol       Date:  1978-07       Impact factor: 5.422

8.  Affinity isolation and characterization of immunoglobulin G Fc fragment-binding glycoprotein from human blood platelets.

Authors:  C M Cheng; J Hawiger
Journal:  J Biol Chem       Date:  1979-04-10       Impact factor: 5.157

9.  Studies of the mechanism of the human platelet release reaction induced by immunologic stimuli. III. Relationship between the binding of soluble IgG aggregates to the Fc receptor and cell response in the presence and absence of plasma.

Authors:  S L Pfueller; S Weber; E F Lüscher
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

10.  The use of lead citrate at high pH as an electron-opaque stain in electron microscopy.

Authors:  E S REYNOLDS
Journal:  J Cell Biol       Date:  1963-04       Impact factor: 10.539

View more
  22 in total

Review 1.  Platelet-bacterial interactions.

Authors:  Steven W Kerrigan; Dermot Cox
Journal:  Cell Mol Life Sci       Date:  2009-11-29       Impact factor: 9.261

2.  ADP-dependent common receptor mechanism for binding of von Willebrand factor and fibrinogen to human platelets.

Authors:  S Timmons; M Kloczewiak; J Hawiger
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

3.  Intravascular coagulation in mice by the compact-colony-forming active substance (CCFAS) extracted from a strain of Staphylococcus aureus.

Authors:  K Yoshida; T Ohtomo; Y Ichiman; S Narikawa; K Oikawa
Journal:  Br J Exp Pathol       Date:  1981-12

4.  Mechanisms of platelet aggregation by viridans group streptococci.

Authors:  P M Sullam; F H Valone; J Mills
Journal:  Infect Immun       Date:  1987-08       Impact factor: 3.441

5.  Platelet antistaphylococcal responses occur through P2X1 and P2Y12 receptor-induced activation and kinocidin release.

Authors:  Darin A Trier; Kimberly D Gank; Deborah Kupferwasser; Nannette Y Yount; William J French; Alan D Michelson; Leon I Kupferwasser; Yan Q Xiong; Arnold S Bayer; Michael R Yeaman
Journal:  Infect Immun       Date:  2008-09-29       Impact factor: 3.441

6.  Cell-free released components of Streptococcus sanguis inhibit human platelet aggregation.

Authors:  M C Herzberg; K L Brintzenhofe; C C Clawson
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

7.  Treatment of septic thrombocytopenia with immune globulin.

Authors:  E R Burns; V Lee; A Rubinstein
Journal:  J Clin Immunol       Date:  1991-11       Impact factor: 8.317

8.  Thrombin-induced exposure and prostacyclin inhibition of the receptor for factor VIII/von Willebrand factor on human platelets.

Authors:  T Fujimoto; S Ohara; J Hawiger
Journal:  J Clin Invest       Date:  1982-06       Impact factor: 14.808

9.  Interaction of rat platelets with Listeria monocytogenes.

Authors:  C J Czuprynski; E Balish
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.441

Review 10.  Platelets in defense against bacterial pathogens.

Authors:  Michael R Yeaman
Journal:  Cell Mol Life Sci       Date:  2009-12-15       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.